본문 바로가기

추천 검색어

실시간 인기 검색어

학술논문

망막분지정맥폐쇄에 동반된 황반부종의 유리체내 베바시주맙 및 후테논낭하 트리암시놀론 병합요법

이용수 0

영문명
Combined Therapy of Intravitreal Bevacizumab and Posterior Subtenon Triamcinolone Injection in Macular Edema with Branch Retinal Vein Occlusion
발행기관
대한안과학회
저자명
조아란 최경식 이미리 이성진,Aran Cho, MD, Kyung Seek Choi, MD, PhD, Mi Ri Rhee, MD, Sung Jin Lee, MD, PhD
간행물 정보
『대한안과학회지』Ophthalmological Society,volume53,number2, 276~282쪽, 전체 7쪽
주제분류
의약학 > 기타의약학
파일형태
PDF
발행일자
2012.02.15
4,000

구매일시로부터 72시간 이내에 다운로드 가능합니다.
이 학술논문 정보는 (주)교보문고와 각 발행기관 사이에 저작물 이용 계약이 체결된 것으로, 교보문고를 통해 제공되고 있습니다.

1:1 문의
논문 표지

국문 초록

영문 초록

Purpose: To compare the clinical outcomes of intravitreal bevacizumab with and without posterior subtenon triamcinolone acetonide injections for macular edema with branch retinal vein occlusion. Methods: Intravitreal bevacizumab injection (single group) or intravitreal bevacizumab injection with posterior subtenon triamcinolone acetonide injection (combined group) were performed in 30 eyes each, and intravitreal bevacizumab injection was given once a month in both groups until macular edema was in the normal range. A best corrected visual acuity and central macular thickness were measured pre- and post- injection. Results: The required number of injections to achieve improved macular edema in the normal range was 2.8 ± 0.5 times in the single group and 2.0 ± 0.6 times in the combined group. Six months after injection, average central macular thickness decreased to 185.3 ± 63.5 μm in the single group and to 260.0 ± 74.6 μm in the combined group. The best corrected visual acuity (log MAR) improved from 0.71 ± 0.63 to 0.35 ± 0.44 in the single group and from 0.67 ± 0.42 to 0.08 ± 0.11 in the combined group. The number of cases in which the central macular thickness increased again within 6 months after the injections was 19 eyes in the single group and 6 eyes in the combined group. Conclusions: In macular edema with branch retinal vein occlusion, early rapid recovery of visual acuity and decrease of central macular thickness were observed due to the synergistic effect of bevacizumab and triamcinolone acetonide in combined therapy, and the recurrence frequency of macular edema was reduced by the long-term effect instilled by the long half-life of triamcinolone acetonide. J Korean Ophthalmol Soc 2012;53(2):276-282

목차

키워드

해당간행물 수록 논문

참고문헌

교보eBook 첫 방문을 환영 합니다!

신규가입 혜택 지급이 완료 되었습니다.

바로 사용 가능한 교보e캐시 1,000원 (유효기간 7일)
지금 바로 교보eBook의 다양한 콘텐츠를 이용해 보세요!

교보e캐시 1,000원
TOP
인용하기
APA

조아란,최경식,이미리,이성진,Aran Cho, MD, Kyung Seek Choi, MD, PhD, Mi Ri Rhee, MD, Sung Jin Lee, MD, PhD. (2012).망막분지정맥폐쇄에 동반된 황반부종의 유리체내 베바시주맙 및 후테논낭하 트리암시놀론 병합요법. 대한안과학회지, 53 (2), 276-282

MLA

조아란,최경식,이미리,이성진,Aran Cho, MD, Kyung Seek Choi, MD, PhD, Mi Ri Rhee, MD, Sung Jin Lee, MD, PhD. "망막분지정맥폐쇄에 동반된 황반부종의 유리체내 베바시주맙 및 후테논낭하 트리암시놀론 병합요법." 대한안과학회지, 53.2(2012): 276-282

결제완료
e캐시 원 결제 계속 하시겠습니까?
교보 e캐시 간편 결제